PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
July 2, 2026Journal of Neuroendocrinology

Controversies in NEN : An ENETS position statement on the interchangeability of somatostatin receptor PET tracers

View Full Paper
Ask AI
Bookmark
Share

Authors

CDChristophe M. DerooseVAValentina AmbrosiniJHJohannes Hofland

Discussion

Loading...

Member takes

Overview

Position statement reviews PET tracer interchangeability for neuroendocrine tumors, guiding clinical practice.

Key Points

  • To evaluate the interchangeability of somatostatin receptor PET tracers in neuroendocrine neoplasms.
  • Overview of existing evidence regarding somatostatin receptor imaging.
  • Comparison of novel PET tracers, including fluorine‐18 and copper‐64.
  • Guidance provided for clinicians on contemporary SSTR PET usage.
  • Different radionuclide tracers may impact imaging results and patient management.
  • Antagonist tracers could enhance patient selection for targeted therapies.
  • The paper addresses the clinical relevance of tracer interchangeability.

Cite This Study

Deroose et al. (2026) studied this question.

synapsesocial.com/papers/6a4600a29ed1343031310b2dhttps://doi.org/10.1111/jne.70220
View Full Paper
Ask AI
Bookmark
Share